• Clinical Guidelines
  • A code of practice for declaring and dealing with competing interests
  • About Cancer Council’s Clinical Practice Guidelines
  • Adolescents and young adults (AYA) cancer clinical guidelines
    • Early detection of cancer in AYAs
    • Psychosocial management of AYAs diagnosed with cancer: Guidance for health professionals
  • Clinical practice guidelines for teleoncology
  • Oesophageal cancer clinical guidelines
    • Clinical practice guidelines for the diagnosis and management of Barrett’s oesophagus and early oesophageal adenocarcinoma
  • Bowel cancer clinical guidelines
    • Clinical practice guidelines for the prevention, early detection and management of colorectal cancer
    • Clinical practice guidelines for surveillance colonoscopy
  • COSA guidelines for the safe prescribing, dispensing and administration of systemic cancer therapy
  • Cervical cancer clinical guidelines
    • National cervical screening program
      • Appendices
        • Appendix B
        • Appendix C
        • Appendix D
        • Appendix E
        • Appendix F
        • Appendix G
        • Appendix H
        • Appendix J
        • Appendix I
        • Appendix A
      • Cervical Cancer Screening Guideline July 2022 Updates - PDFs
      • Foreword
      • 17. DES-exposed women
      • Introduction
      • 10. Management of histologically confirmed high-grade squamous abnormalities
        • Diagnosis of high-grade squamous abnormalities
        • Management of histologically confirmed high-grade squamous abnormalities
        • Test of Cure after treatment for HSIL (CIN2/3)
        • Treatment of high-grade squamous abnormalities
      • 11. Management of glandular abnormalities
        • Management of histologically confirmed high-grade glandular abnormalities
        • Follow-up after excisional treatment for AIS
        • Investigation of cytological glandular abnormalities
      • 12. HPV screening strategies for Aboriginal and Torres Strait Islander women
      • 13. Screening after total hysterectomy
      • 14. Screening in pregnancy
      • 15. Women experienced early sexual activity or victims of abuse
      • 16. Screening in immune-deficient women
      • 18. Signs and symptoms of cervical cancer
        • Investigations of other symptoms: vaginal discharge and deep dyspareunia
        • Investigation of abnormal vaginal bleeding
      • 19. Psychosocial care
      • 1. Cervical cancer in Australia
      • 20. Transition to the renewed National Cervical Screening Program
      • 3. Terminology
        • Cytology and AMBS 2004 terminology for reporting
        • Histopathology
        • HPV testing terminology
        • Preparation of cervical screening reports
        • Supplement: Sample reports
      • 4. Unsatisfactory cervical screening results
      • 5. Benefits, harms and cost-effectiveness in renewed National Cervical Screening Program (NCSP)
      • 6. Management of oncogenic HPV test results
        • Management of HPV test results
        • Medical Services Advisory Committee recommendations for HPV testing
        • Oncogenic HPV types not 16/18
        • Oncogenic HPV types 16 and/or 18
        • Oncogenic HPV types not detected
        • Screening in women older than 75
        • Self-collected vaginal samples
        • Flowcharts: Management of oncogenic HPV test results
        • Women undergoing exit testing
      • 7. Colposcopy
        • Colposcopy data for the National Cancer Screening Register
        • Colposcopy terminology
        • History, examination and investigation
        • Principles of practice
        • Quality improvement in colposcopy
        • Supplement. Colposcopy information for discussion with patient
        • Supplement. Colposcopy technologies and documentation
        • Colposcopy and treatment
      • 8. Management of discordant colposcopic impression, histopathology and referral LBC prediction
        • Management of discordant colposcopic impression, histopathology and referral LBC prediction
        • Normal colposcopic findings following LBC prediction of Negative, LSIL or HSIL
        • Type 3 TZ (previously termed ‘unsatisfactory’) colposcopy following LBC prediction of Negative, LSIL or HSIL
      • 9. Management of histologically confirmed low-grade squamous abnormalities
      • 2. The rationale for primary HPV screening
      • Summary of recommendations
  • Clinical practice guidelines for the treatment and management of endometrial cancer
  • Browse all clinical guidelines
    • Early detection of cancer in AYA
  • Lung cancer clinical guidelines
    • Clinical practice guidelines for the treatment of lung cancer
    • Clinical practice guidelines for the prevention and diagnosis of lung cancer
  • Clinical practice guideline for the management of communication and swallowing in children diagnosed with childhood brain tumour or leukaemia
  • Cancer pain management in adults clinical guidelines
  • Prostate cancer clinical guidelines
    • Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer
  • Skin cancer clinical guidelines
    • Clinical practice guidelines for keratinocyte cancer
    • Clinical practice guidelines for the diagnosis and management of melanoma
  • Archive of clinical guidelines and resources
  • COSA guidelines for fertility preservation for people with cancer
    • Appendices
      • Additional resources
      • COSA Fertility Preservation Guidelines Working Group
      • Guideline development process
    • Contraception
      • Contraception after cancer treatment
      • Cancer Fertility Preservation
    • Discussing Risk
      • Reproductive concerns
      • Health professional awareness
      • Role of oncology services
    • Impact on fertility
      • Pregnancy and live birth
      • Ovarian function
      • Testicular function
    • Pubertal development
    • Pregnancy
      • Pregnancy and risk of cancer recurrence
      • Risk of pregnancy complications
    • Psychological support
      • Decision making
      • Fertility counselling
    • Referral and service provision
      • Oncofertility service provision
      • Referral rates and decisional conflict
      • Referral pathways
    • Summary of recommendations
    • Options for treatment
      • Embryo cryopreservation
      • Oocyte cryopreservation
      • Safety of ovarian stimulation
      • Ovarian suppression with GnRH analogues
      • Ovarian tissue cryopreservation
      • Ovarian transposition
      • Sperm cryopreservation
      • Testicular biopsy
    • Conception
      • Assisted reproduction and risk of cancer recurrence
      • Interrupting hormone therapy to conceive
  • Evidence-based practice guidelines for the nutritional management of adult patients with head and neck cancer
  • Liver cancer clinical guidelines
    • Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia
  • Neuroendocrine neoplasms (NENs) consensus guidelines